Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/affordable-drugs-need-a-compensatory-patent-commons-shamnad-basheer-4678089/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/affordable-drugs-need-a-compensatory-patent-commons-shamnad-basheer-4678089/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/affordable-drugs-need-a-compensatory-patent-commons-shamnad-basheer-4678089/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/affordable-drugs-need-a-compensatory-patent-commons-shamnad-basheer-4678089/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f0cdfc4bf5f-trace').style.display = (document.getElementById('cakeErr67f0cdfc4bf5f-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f0cdfc4bf5f-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f0cdfc4bf5f-code').style.display = (document.getElementById('cakeErr67f0cdfc4bf5f-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f0cdfc4bf5f-context').style.display = (document.getElementById('cakeErr67f0cdfc4bf5f-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f0cdfc4bf5f-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f0cdfc4bf5f-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 30030,
		&#039;title&#039; =&gt; &#039;Affordable Drugs Need a Compensatory Patent Commons -Shamnad Basheer&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-TheWire.in&lt;br /&gt;
&lt;br /&gt;
In a case that will once again prove that India is not out to arbitrarily purge all pharmaceutical patents, the Delhi high court has ruled in favour of Roche, a Swiss multinational. Many years ago, Roche dragged Cipla to court arguing that Cipla&amp;rsquo;s product infringed its patented anticancer drug, Erlotinib (brand name &amp;lsquo;Tarceva&amp;rsquo;). After a protracted legal battle fought over seven hard years, Roche finally won.&lt;br /&gt;
&lt;br /&gt;
But so did Cipla. Indeed, the ingenuity of our judges is such that we&amp;rsquo;ve craftily converted our patent system from a harsh zero sum game to a win-win for both. Cipla&amp;rsquo;s gamble appears to have paid off. Here&amp;rsquo;s how.&lt;br /&gt;
&lt;br /&gt;
In late 2008, in what will perhaps rate as one of the most adventurous patent joyrides ever, Cipla brazenly launched Erlocip, a generic version of Roche&amp;rsquo;s patented Tarceva. Roche lost no time in initiating legal action before the Delhi High Court. Cipla mounted a spirited defence, challenging the validity of Roche&amp;rsquo;s patent and taking shelter under the &amp;ldquo;public interest&amp;rdquo; defence, arguing that its generic version (sold at approx. Rs 50,000 a month) was far cheaper than the patented version (at Rs 1.5 lakhs) and therefore more accessible to patients in India.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;Please &lt;a href=&quot;http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/&quot;&gt;click here&lt;/a&gt; to read more. &lt;/em&gt;&lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Economic Times, 17 December, 2015, http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;affordable-drugs-need-a-compensatory-patent-commons-shamnad-basheer-4678089&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4678089,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 30030,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Affordable Drugs Need a Compensatory Patent Commons -Shamnad Basheer&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;generic medicine,generic medicines,patent,patents&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-TheWire.in

In a case that will once again prove that India is not out to arbitrarily purge all pharmaceutical patents, the Delhi high court has ruled in favour of Roche, a Swiss multinational. Many years ago, Roche dragged Cipla to court...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-TheWire.in&lt;br /&gt;&lt;br /&gt;In a case that will once again prove that India is not out to arbitrarily purge all pharmaceutical patents, the Delhi high court has ruled in favour of Roche, a Swiss multinational. Many years ago, Roche dragged Cipla to court arguing that Cipla&amp;rsquo;s product infringed its patented anticancer drug, Erlotinib (brand name &amp;lsquo;Tarceva&amp;rsquo;). After a protracted legal battle fought over seven hard years, Roche finally won.&lt;br /&gt;&lt;br /&gt;But so did Cipla. Indeed, the ingenuity of our judges is such that we&amp;rsquo;ve craftily converted our patent system from a harsh zero sum game to a win-win for both. Cipla&amp;rsquo;s gamble appears to have paid off. Here&amp;rsquo;s how.&lt;br /&gt;&lt;br /&gt;In late 2008, in what will perhaps rate as one of the most adventurous patent joyrides ever, Cipla brazenly launched Erlocip, a generic version of Roche&amp;rsquo;s patented Tarceva. Roche lost no time in initiating legal action before the Delhi High Court. Cipla mounted a spirited defence, challenging the validity of Roche&amp;rsquo;s patent and taking shelter under the &amp;ldquo;public interest&amp;rdquo; defence, arguing that its generic version (sold at approx. Rs 50,000 a month) was far cheaper than the patented version (at Rs 1.5 lakhs) and therefore more accessible to patients in India.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;Please &lt;a href=&quot;http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/&quot; title=&quot;http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/&quot;&gt;click here&lt;/a&gt; to read more. &lt;/em&gt;&lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 30030,
	&#039;title&#039; =&gt; &#039;Affordable Drugs Need a Compensatory Patent Commons -Shamnad Basheer&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-TheWire.in&lt;br /&gt;
&lt;br /&gt;
In a case that will once again prove that India is not out to arbitrarily purge all pharmaceutical patents, the Delhi high court has ruled in favour of Roche, a Swiss multinational. Many years ago, Roche dragged Cipla to court arguing that Cipla&amp;rsquo;s product infringed its patented anticancer drug, Erlotinib (brand name &amp;lsquo;Tarceva&amp;rsquo;). After a protracted legal battle fought over seven hard years, Roche finally won.&lt;br /&gt;
&lt;br /&gt;
But so did Cipla. Indeed, the ingenuity of our judges is such that we&amp;rsquo;ve craftily converted our patent system from a harsh zero sum game to a win-win for both. Cipla&amp;rsquo;s gamble appears to have paid off. Here&amp;rsquo;s how.&lt;br /&gt;
&lt;br /&gt;
In late 2008, in what will perhaps rate as one of the most adventurous patent joyrides ever, Cipla brazenly launched Erlocip, a generic version of Roche&amp;rsquo;s patented Tarceva. Roche lost no time in initiating legal action before the Delhi High Court. Cipla mounted a spirited defence, challenging the validity of Roche&amp;rsquo;s patent and taking shelter under the &amp;ldquo;public interest&amp;rdquo; defence, arguing that its generic version (sold at approx. Rs 50,000 a month) was far cheaper than the patented version (at Rs 1.5 lakhs) and therefore more accessible to patients in India.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;Please &lt;a href=&quot;http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/&quot;&gt;click here&lt;/a&gt; to read more. &lt;/em&gt;&lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Economic Times, 17 December, 2015, http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;affordable-drugs-need-a-compensatory-patent-commons-shamnad-basheer-4678089&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4678089,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 30030
$metaTitle = &#039;LATEST NEWS UPDATES | Affordable Drugs Need a Compensatory Patent Commons -Shamnad Basheer&#039;
$metaKeywords = &#039;generic medicine,generic medicines,patent,patents&#039;
$metaDesc = &#039;
-TheWire.in

In a case that will once again prove that India is not out to arbitrarily purge all pharmaceutical patents, the Delhi high court has ruled in favour of Roche, a Swiss multinational. Many years ago, Roche dragged Cipla to court...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-TheWire.in&lt;br /&gt;&lt;br /&gt;In a case that will once again prove that India is not out to arbitrarily purge all pharmaceutical patents, the Delhi high court has ruled in favour of Roche, a Swiss multinational. Many years ago, Roche dragged Cipla to court arguing that Cipla&amp;rsquo;s product infringed its patented anticancer drug, Erlotinib (brand name &amp;lsquo;Tarceva&amp;rsquo;). After a protracted legal battle fought over seven hard years, Roche finally won.&lt;br /&gt;&lt;br /&gt;But so did Cipla. Indeed, the ingenuity of our judges is such that we&amp;rsquo;ve craftily converted our patent system from a harsh zero sum game to a win-win for both. Cipla&amp;rsquo;s gamble appears to have paid off. Here&amp;rsquo;s how.&lt;br /&gt;&lt;br /&gt;In late 2008, in what will perhaps rate as one of the most adventurous patent joyrides ever, Cipla brazenly launched Erlocip, a generic version of Roche&amp;rsquo;s patented Tarceva. Roche lost no time in initiating legal action before the Delhi High Court. Cipla mounted a spirited defence, challenging the validity of Roche&amp;rsquo;s patent and taking shelter under the &amp;ldquo;public interest&amp;rdquo; defence, arguing that its generic version (sold at approx. Rs 50,000 a month) was far cheaper than the patented version (at Rs 1.5 lakhs) and therefore more accessible to patients in India.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;Please &lt;a href=&quot;http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/&quot; title=&quot;http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/&quot;&gt;click here&lt;/a&gt; to read more. &lt;/em&gt;&lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/affordable-drugs-need-a-compensatory-patent-commons-shamnad-basheer-4678089.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Affordable Drugs Need a Compensatory Patent Commons -Shamnad Basheer | Im4change.org</title>
    <meta name="description" content="
-TheWire.in

In a case that will once again prove that India is not out to arbitrarily purge all pharmaceutical patents, the Delhi high court has ruled in favour of Roche, a Swiss multinational. Many years ago, Roche dragged Cipla to court..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Affordable Drugs Need a Compensatory Patent Commons -Shamnad Basheer</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-TheWire.in<br /><br />In a case that will once again prove that India is not out to arbitrarily purge all pharmaceutical patents, the Delhi high court has ruled in favour of Roche, a Swiss multinational. Many years ago, Roche dragged Cipla to court arguing that Cipla&rsquo;s product infringed its patented anticancer drug, Erlotinib (brand name &lsquo;Tarceva&rsquo;). After a protracted legal battle fought over seven hard years, Roche finally won.<br /><br />But so did Cipla. Indeed, the ingenuity of our judges is such that we&rsquo;ve craftily converted our patent system from a harsh zero sum game to a win-win for both. Cipla&rsquo;s gamble appears to have paid off. Here&rsquo;s how.<br /><br />In late 2008, in what will perhaps rate as one of the most adventurous patent joyrides ever, Cipla brazenly launched Erlocip, a generic version of Roche&rsquo;s patented Tarceva. Roche lost no time in initiating legal action before the Delhi High Court. Cipla mounted a spirited defence, challenging the validity of Roche&rsquo;s patent and taking shelter under the &ldquo;public interest&rdquo; defence, arguing that its generic version (sold at approx. Rs 50,000 a month) was far cheaper than the patented version (at Rs 1.5 lakhs) and therefore more accessible to patients in India.<br /><br /><em>Please <a href="http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/" title="http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/">click here</a> to read more. </em><br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f0cdfc4bf5f-trace').style.display = (document.getElementById('cakeErr67f0cdfc4bf5f-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f0cdfc4bf5f-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f0cdfc4bf5f-code').style.display = (document.getElementById('cakeErr67f0cdfc4bf5f-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f0cdfc4bf5f-context').style.display = (document.getElementById('cakeErr67f0cdfc4bf5f-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f0cdfc4bf5f-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f0cdfc4bf5f-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 30030,
		&#039;title&#039; =&gt; &#039;Affordable Drugs Need a Compensatory Patent Commons -Shamnad Basheer&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-TheWire.in&lt;br /&gt;
&lt;br /&gt;
In a case that will once again prove that India is not out to arbitrarily purge all pharmaceutical patents, the Delhi high court has ruled in favour of Roche, a Swiss multinational. Many years ago, Roche dragged Cipla to court arguing that Cipla&amp;rsquo;s product infringed its patented anticancer drug, Erlotinib (brand name &amp;lsquo;Tarceva&amp;rsquo;). After a protracted legal battle fought over seven hard years, Roche finally won.&lt;br /&gt;
&lt;br /&gt;
But so did Cipla. Indeed, the ingenuity of our judges is such that we&amp;rsquo;ve craftily converted our patent system from a harsh zero sum game to a win-win for both. Cipla&amp;rsquo;s gamble appears to have paid off. Here&amp;rsquo;s how.&lt;br /&gt;
&lt;br /&gt;
In late 2008, in what will perhaps rate as one of the most adventurous patent joyrides ever, Cipla brazenly launched Erlocip, a generic version of Roche&amp;rsquo;s patented Tarceva. Roche lost no time in initiating legal action before the Delhi High Court. Cipla mounted a spirited defence, challenging the validity of Roche&amp;rsquo;s patent and taking shelter under the &amp;ldquo;public interest&amp;rdquo; defence, arguing that its generic version (sold at approx. Rs 50,000 a month) was far cheaper than the patented version (at Rs 1.5 lakhs) and therefore more accessible to patients in India.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;Please &lt;a href=&quot;http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/&quot;&gt;click here&lt;/a&gt; to read more. &lt;/em&gt;&lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Economic Times, 17 December, 2015, http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;affordable-drugs-need-a-compensatory-patent-commons-shamnad-basheer-4678089&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4678089,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 30030,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Affordable Drugs Need a Compensatory Patent Commons -Shamnad Basheer&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;generic medicine,generic medicines,patent,patents&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-TheWire.in

In a case that will once again prove that India is not out to arbitrarily purge all pharmaceutical patents, the Delhi high court has ruled in favour of Roche, a Swiss multinational. Many years ago, Roche dragged Cipla to court...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-TheWire.in&lt;br /&gt;&lt;br /&gt;In a case that will once again prove that India is not out to arbitrarily purge all pharmaceutical patents, the Delhi high court has ruled in favour of Roche, a Swiss multinational. Many years ago, Roche dragged Cipla to court arguing that Cipla&amp;rsquo;s product infringed its patented anticancer drug, Erlotinib (brand name &amp;lsquo;Tarceva&amp;rsquo;). After a protracted legal battle fought over seven hard years, Roche finally won.&lt;br /&gt;&lt;br /&gt;But so did Cipla. Indeed, the ingenuity of our judges is such that we&amp;rsquo;ve craftily converted our patent system from a harsh zero sum game to a win-win for both. Cipla&amp;rsquo;s gamble appears to have paid off. Here&amp;rsquo;s how.&lt;br /&gt;&lt;br /&gt;In late 2008, in what will perhaps rate as one of the most adventurous patent joyrides ever, Cipla brazenly launched Erlocip, a generic version of Roche&amp;rsquo;s patented Tarceva. Roche lost no time in initiating legal action before the Delhi High Court. Cipla mounted a spirited defence, challenging the validity of Roche&amp;rsquo;s patent and taking shelter under the &amp;ldquo;public interest&amp;rdquo; defence, arguing that its generic version (sold at approx. Rs 50,000 a month) was far cheaper than the patented version (at Rs 1.5 lakhs) and therefore more accessible to patients in India.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;Please &lt;a href=&quot;http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/&quot; title=&quot;http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/&quot;&gt;click here&lt;/a&gt; to read more. &lt;/em&gt;&lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 30030,
	&#039;title&#039; =&gt; &#039;Affordable Drugs Need a Compensatory Patent Commons -Shamnad Basheer&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-TheWire.in&lt;br /&gt;
&lt;br /&gt;
In a case that will once again prove that India is not out to arbitrarily purge all pharmaceutical patents, the Delhi high court has ruled in favour of Roche, a Swiss multinational. Many years ago, Roche dragged Cipla to court arguing that Cipla&amp;rsquo;s product infringed its patented anticancer drug, Erlotinib (brand name &amp;lsquo;Tarceva&amp;rsquo;). After a protracted legal battle fought over seven hard years, Roche finally won.&lt;br /&gt;
&lt;br /&gt;
But so did Cipla. Indeed, the ingenuity of our judges is such that we&amp;rsquo;ve craftily converted our patent system from a harsh zero sum game to a win-win for both. Cipla&amp;rsquo;s gamble appears to have paid off. Here&amp;rsquo;s how.&lt;br /&gt;
&lt;br /&gt;
In late 2008, in what will perhaps rate as one of the most adventurous patent joyrides ever, Cipla brazenly launched Erlocip, a generic version of Roche&amp;rsquo;s patented Tarceva. Roche lost no time in initiating legal action before the Delhi High Court. Cipla mounted a spirited defence, challenging the validity of Roche&amp;rsquo;s patent and taking shelter under the &amp;ldquo;public interest&amp;rdquo; defence, arguing that its generic version (sold at approx. Rs 50,000 a month) was far cheaper than the patented version (at Rs 1.5 lakhs) and therefore more accessible to patients in India.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;Please &lt;a href=&quot;http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/&quot;&gt;click here&lt;/a&gt; to read more. &lt;/em&gt;&lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Economic Times, 17 December, 2015, http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;affordable-drugs-need-a-compensatory-patent-commons-shamnad-basheer-4678089&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4678089,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 30030
$metaTitle = &#039;LATEST NEWS UPDATES | Affordable Drugs Need a Compensatory Patent Commons -Shamnad Basheer&#039;
$metaKeywords = &#039;generic medicine,generic medicines,patent,patents&#039;
$metaDesc = &#039;
-TheWire.in

In a case that will once again prove that India is not out to arbitrarily purge all pharmaceutical patents, the Delhi high court has ruled in favour of Roche, a Swiss multinational. Many years ago, Roche dragged Cipla to court...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-TheWire.in&lt;br /&gt;&lt;br /&gt;In a case that will once again prove that India is not out to arbitrarily purge all pharmaceutical patents, the Delhi high court has ruled in favour of Roche, a Swiss multinational. Many years ago, Roche dragged Cipla to court arguing that Cipla&amp;rsquo;s product infringed its patented anticancer drug, Erlotinib (brand name &amp;lsquo;Tarceva&amp;rsquo;). After a protracted legal battle fought over seven hard years, Roche finally won.&lt;br /&gt;&lt;br /&gt;But so did Cipla. Indeed, the ingenuity of our judges is such that we&amp;rsquo;ve craftily converted our patent system from a harsh zero sum game to a win-win for both. Cipla&amp;rsquo;s gamble appears to have paid off. Here&amp;rsquo;s how.&lt;br /&gt;&lt;br /&gt;In late 2008, in what will perhaps rate as one of the most adventurous patent joyrides ever, Cipla brazenly launched Erlocip, a generic version of Roche&amp;rsquo;s patented Tarceva. Roche lost no time in initiating legal action before the Delhi High Court. Cipla mounted a spirited defence, challenging the validity of Roche&amp;rsquo;s patent and taking shelter under the &amp;ldquo;public interest&amp;rdquo; defence, arguing that its generic version (sold at approx. Rs 50,000 a month) was far cheaper than the patented version (at Rs 1.5 lakhs) and therefore more accessible to patients in India.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;Please &lt;a href=&quot;http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/&quot; title=&quot;http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/&quot;&gt;click here&lt;/a&gt; to read more. &lt;/em&gt;&lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/affordable-drugs-need-a-compensatory-patent-commons-shamnad-basheer-4678089.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Affordable Drugs Need a Compensatory Patent Commons -Shamnad Basheer | Im4change.org</title>
    <meta name="description" content="
-TheWire.in

In a case that will once again prove that India is not out to arbitrarily purge all pharmaceutical patents, the Delhi high court has ruled in favour of Roche, a Swiss multinational. Many years ago, Roche dragged Cipla to court..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Affordable Drugs Need a Compensatory Patent Commons -Shamnad Basheer</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-TheWire.in<br /><br />In a case that will once again prove that India is not out to arbitrarily purge all pharmaceutical patents, the Delhi high court has ruled in favour of Roche, a Swiss multinational. Many years ago, Roche dragged Cipla to court arguing that Cipla&rsquo;s product infringed its patented anticancer drug, Erlotinib (brand name &lsquo;Tarceva&rsquo;). After a protracted legal battle fought over seven hard years, Roche finally won.<br /><br />But so did Cipla. Indeed, the ingenuity of our judges is such that we&rsquo;ve craftily converted our patent system from a harsh zero sum game to a win-win for both. Cipla&rsquo;s gamble appears to have paid off. Here&rsquo;s how.<br /><br />In late 2008, in what will perhaps rate as one of the most adventurous patent joyrides ever, Cipla brazenly launched Erlocip, a generic version of Roche&rsquo;s patented Tarceva. Roche lost no time in initiating legal action before the Delhi High Court. Cipla mounted a spirited defence, challenging the validity of Roche&rsquo;s patent and taking shelter under the &ldquo;public interest&rdquo; defence, arguing that its generic version (sold at approx. Rs 50,000 a month) was far cheaper than the patented version (at Rs 1.5 lakhs) and therefore more accessible to patients in India.<br /><br /><em>Please <a href="http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/" title="http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/">click here</a> to read more. </em><br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f0cdfc4bf5f-trace').style.display = (document.getElementById('cakeErr67f0cdfc4bf5f-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f0cdfc4bf5f-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f0cdfc4bf5f-code').style.display = (document.getElementById('cakeErr67f0cdfc4bf5f-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f0cdfc4bf5f-context').style.display = (document.getElementById('cakeErr67f0cdfc4bf5f-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f0cdfc4bf5f-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f0cdfc4bf5f-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 30030,
		&#039;title&#039; =&gt; &#039;Affordable Drugs Need a Compensatory Patent Commons -Shamnad Basheer&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-TheWire.in&lt;br /&gt;
&lt;br /&gt;
In a case that will once again prove that India is not out to arbitrarily purge all pharmaceutical patents, the Delhi high court has ruled in favour of Roche, a Swiss multinational. Many years ago, Roche dragged Cipla to court arguing that Cipla&amp;rsquo;s product infringed its patented anticancer drug, Erlotinib (brand name &amp;lsquo;Tarceva&amp;rsquo;). After a protracted legal battle fought over seven hard years, Roche finally won.&lt;br /&gt;
&lt;br /&gt;
But so did Cipla. Indeed, the ingenuity of our judges is such that we&amp;rsquo;ve craftily converted our patent system from a harsh zero sum game to a win-win for both. Cipla&amp;rsquo;s gamble appears to have paid off. Here&amp;rsquo;s how.&lt;br /&gt;
&lt;br /&gt;
In late 2008, in what will perhaps rate as one of the most adventurous patent joyrides ever, Cipla brazenly launched Erlocip, a generic version of Roche&amp;rsquo;s patented Tarceva. Roche lost no time in initiating legal action before the Delhi High Court. Cipla mounted a spirited defence, challenging the validity of Roche&amp;rsquo;s patent and taking shelter under the &amp;ldquo;public interest&amp;rdquo; defence, arguing that its generic version (sold at approx. Rs 50,000 a month) was far cheaper than the patented version (at Rs 1.5 lakhs) and therefore more accessible to patients in India.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;Please &lt;a href=&quot;http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/&quot;&gt;click here&lt;/a&gt; to read more. &lt;/em&gt;&lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Economic Times, 17 December, 2015, http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;affordable-drugs-need-a-compensatory-patent-commons-shamnad-basheer-4678089&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4678089,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 30030,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Affordable Drugs Need a Compensatory Patent Commons -Shamnad Basheer&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;generic medicine,generic medicines,patent,patents&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-TheWire.in

In a case that will once again prove that India is not out to arbitrarily purge all pharmaceutical patents, the Delhi high court has ruled in favour of Roche, a Swiss multinational. Many years ago, Roche dragged Cipla to court...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-TheWire.in&lt;br /&gt;&lt;br /&gt;In a case that will once again prove that India is not out to arbitrarily purge all pharmaceutical patents, the Delhi high court has ruled in favour of Roche, a Swiss multinational. Many years ago, Roche dragged Cipla to court arguing that Cipla&amp;rsquo;s product infringed its patented anticancer drug, Erlotinib (brand name &amp;lsquo;Tarceva&amp;rsquo;). After a protracted legal battle fought over seven hard years, Roche finally won.&lt;br /&gt;&lt;br /&gt;But so did Cipla. Indeed, the ingenuity of our judges is such that we&amp;rsquo;ve craftily converted our patent system from a harsh zero sum game to a win-win for both. Cipla&amp;rsquo;s gamble appears to have paid off. Here&amp;rsquo;s how.&lt;br /&gt;&lt;br /&gt;In late 2008, in what will perhaps rate as one of the most adventurous patent joyrides ever, Cipla brazenly launched Erlocip, a generic version of Roche&amp;rsquo;s patented Tarceva. Roche lost no time in initiating legal action before the Delhi High Court. Cipla mounted a spirited defence, challenging the validity of Roche&amp;rsquo;s patent and taking shelter under the &amp;ldquo;public interest&amp;rdquo; defence, arguing that its generic version (sold at approx. Rs 50,000 a month) was far cheaper than the patented version (at Rs 1.5 lakhs) and therefore more accessible to patients in India.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;Please &lt;a href=&quot;http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/&quot; title=&quot;http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/&quot;&gt;click here&lt;/a&gt; to read more. &lt;/em&gt;&lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 30030,
	&#039;title&#039; =&gt; &#039;Affordable Drugs Need a Compensatory Patent Commons -Shamnad Basheer&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-TheWire.in&lt;br /&gt;
&lt;br /&gt;
In a case that will once again prove that India is not out to arbitrarily purge all pharmaceutical patents, the Delhi high court has ruled in favour of Roche, a Swiss multinational. Many years ago, Roche dragged Cipla to court arguing that Cipla&amp;rsquo;s product infringed its patented anticancer drug, Erlotinib (brand name &amp;lsquo;Tarceva&amp;rsquo;). After a protracted legal battle fought over seven hard years, Roche finally won.&lt;br /&gt;
&lt;br /&gt;
But so did Cipla. Indeed, the ingenuity of our judges is such that we&amp;rsquo;ve craftily converted our patent system from a harsh zero sum game to a win-win for both. Cipla&amp;rsquo;s gamble appears to have paid off. Here&amp;rsquo;s how.&lt;br /&gt;
&lt;br /&gt;
In late 2008, in what will perhaps rate as one of the most adventurous patent joyrides ever, Cipla brazenly launched Erlocip, a generic version of Roche&amp;rsquo;s patented Tarceva. Roche lost no time in initiating legal action before the Delhi High Court. Cipla mounted a spirited defence, challenging the validity of Roche&amp;rsquo;s patent and taking shelter under the &amp;ldquo;public interest&amp;rdquo; defence, arguing that its generic version (sold at approx. Rs 50,000 a month) was far cheaper than the patented version (at Rs 1.5 lakhs) and therefore more accessible to patients in India.&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;Please &lt;a href=&quot;http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/&quot;&gt;click here&lt;/a&gt; to read more. &lt;/em&gt;&lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Economic Times, 17 December, 2015, http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;affordable-drugs-need-a-compensatory-patent-commons-shamnad-basheer-4678089&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4678089,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 30030
$metaTitle = &#039;LATEST NEWS UPDATES | Affordable Drugs Need a Compensatory Patent Commons -Shamnad Basheer&#039;
$metaKeywords = &#039;generic medicine,generic medicines,patent,patents&#039;
$metaDesc = &#039;
-TheWire.in

In a case that will once again prove that India is not out to arbitrarily purge all pharmaceutical patents, the Delhi high court has ruled in favour of Roche, a Swiss multinational. Many years ago, Roche dragged Cipla to court...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-TheWire.in&lt;br /&gt;&lt;br /&gt;In a case that will once again prove that India is not out to arbitrarily purge all pharmaceutical patents, the Delhi high court has ruled in favour of Roche, a Swiss multinational. Many years ago, Roche dragged Cipla to court arguing that Cipla&amp;rsquo;s product infringed its patented anticancer drug, Erlotinib (brand name &amp;lsquo;Tarceva&amp;rsquo;). After a protracted legal battle fought over seven hard years, Roche finally won.&lt;br /&gt;&lt;br /&gt;But so did Cipla. Indeed, the ingenuity of our judges is such that we&amp;rsquo;ve craftily converted our patent system from a harsh zero sum game to a win-win for both. Cipla&amp;rsquo;s gamble appears to have paid off. Here&amp;rsquo;s how.&lt;br /&gt;&lt;br /&gt;In late 2008, in what will perhaps rate as one of the most adventurous patent joyrides ever, Cipla brazenly launched Erlocip, a generic version of Roche&amp;rsquo;s patented Tarceva. Roche lost no time in initiating legal action before the Delhi High Court. Cipla mounted a spirited defence, challenging the validity of Roche&amp;rsquo;s patent and taking shelter under the &amp;ldquo;public interest&amp;rdquo; defence, arguing that its generic version (sold at approx. Rs 50,000 a month) was far cheaper than the patented version (at Rs 1.5 lakhs) and therefore more accessible to patients in India.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;Please &lt;a href=&quot;http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/&quot; title=&quot;http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/&quot;&gt;click here&lt;/a&gt; to read more. &lt;/em&gt;&lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/affordable-drugs-need-a-compensatory-patent-commons-shamnad-basheer-4678089.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Affordable Drugs Need a Compensatory Patent Commons -Shamnad Basheer | Im4change.org</title>
    <meta name="description" content="
-TheWire.in

In a case that will once again prove that India is not out to arbitrarily purge all pharmaceutical patents, the Delhi high court has ruled in favour of Roche, a Swiss multinational. Many years ago, Roche dragged Cipla to court..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Affordable Drugs Need a Compensatory Patent Commons -Shamnad Basheer</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-TheWire.in<br /><br />In a case that will once again prove that India is not out to arbitrarily purge all pharmaceutical patents, the Delhi high court has ruled in favour of Roche, a Swiss multinational. Many years ago, Roche dragged Cipla to court arguing that Cipla&rsquo;s product infringed its patented anticancer drug, Erlotinib (brand name &lsquo;Tarceva&rsquo;). After a protracted legal battle fought over seven hard years, Roche finally won.<br /><br />But so did Cipla. Indeed, the ingenuity of our judges is such that we&rsquo;ve craftily converted our patent system from a harsh zero sum game to a win-win for both. Cipla&rsquo;s gamble appears to have paid off. Here&rsquo;s how.<br /><br />In late 2008, in what will perhaps rate as one of the most adventurous patent joyrides ever, Cipla brazenly launched Erlocip, a generic version of Roche&rsquo;s patented Tarceva. Roche lost no time in initiating legal action before the Delhi High Court. Cipla mounted a spirited defence, challenging the validity of Roche&rsquo;s patent and taking shelter under the &ldquo;public interest&rdquo; defence, arguing that its generic version (sold at approx. Rs 50,000 a month) was far cheaper than the patented version (at Rs 1.5 lakhs) and therefore more accessible to patients in India.<br /><br /><em>Please <a href="http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/" title="http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/">click here</a> to read more. </em><br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 30030,
		'title' => 'Affordable Drugs Need a Compensatory Patent Commons -Shamnad Basheer',
		'subheading' => '',
		'description' => '<div align="justify">
-TheWire.in<br />
<br />
In a case that will once again prove that India is not out to arbitrarily purge all pharmaceutical patents, the Delhi high court has ruled in favour of Roche, a Swiss multinational. Many years ago, Roche dragged Cipla to court arguing that Cipla&rsquo;s product infringed its patented anticancer drug, Erlotinib (brand name &lsquo;Tarceva&rsquo;). After a protracted legal battle fought over seven hard years, Roche finally won.<br />
<br />
But so did Cipla. Indeed, the ingenuity of our judges is such that we&rsquo;ve craftily converted our patent system from a harsh zero sum game to a win-win for both. Cipla&rsquo;s gamble appears to have paid off. Here&rsquo;s how.<br />
<br />
In late 2008, in what will perhaps rate as one of the most adventurous patent joyrides ever, Cipla brazenly launched Erlocip, a generic version of Roche&rsquo;s patented Tarceva. Roche lost no time in initiating legal action before the Delhi High Court. Cipla mounted a spirited defence, challenging the validity of Roche&rsquo;s patent and taking shelter under the &ldquo;public interest&rdquo; defence, arguing that its generic version (sold at approx. Rs 50,000 a month) was far cheaper than the patented version (at Rs 1.5 lakhs) and therefore more accessible to patients in India.<br />
<br />
<em>Please <a href="http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/">click here</a> to read more. </em><br />
</div>',
		'credit_writer' => 'The Economic Times, 17 December, 2015, http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'affordable-drugs-need-a-compensatory-patent-commons-shamnad-basheer-4678089',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 4678089,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 30030,
	'metaTitle' => 'LATEST NEWS UPDATES | Affordable Drugs Need a Compensatory Patent Commons -Shamnad Basheer',
	'metaKeywords' => 'generic medicine,generic medicines,patent,patents',
	'metaDesc' => '
-TheWire.in

In a case that will once again prove that India is not out to arbitrarily purge all pharmaceutical patents, the Delhi high court has ruled in favour of Roche, a Swiss multinational. Many years ago, Roche dragged Cipla to court...',
	'disp' => '<div align="justify">-TheWire.in<br /><br />In a case that will once again prove that India is not out to arbitrarily purge all pharmaceutical patents, the Delhi high court has ruled in favour of Roche, a Swiss multinational. Many years ago, Roche dragged Cipla to court arguing that Cipla&rsquo;s product infringed its patented anticancer drug, Erlotinib (brand name &lsquo;Tarceva&rsquo;). After a protracted legal battle fought over seven hard years, Roche finally won.<br /><br />But so did Cipla. Indeed, the ingenuity of our judges is such that we&rsquo;ve craftily converted our patent system from a harsh zero sum game to a win-win for both. Cipla&rsquo;s gamble appears to have paid off. Here&rsquo;s how.<br /><br />In late 2008, in what will perhaps rate as one of the most adventurous patent joyrides ever, Cipla brazenly launched Erlocip, a generic version of Roche&rsquo;s patented Tarceva. Roche lost no time in initiating legal action before the Delhi High Court. Cipla mounted a spirited defence, challenging the validity of Roche&rsquo;s patent and taking shelter under the &ldquo;public interest&rdquo; defence, arguing that its generic version (sold at approx. Rs 50,000 a month) was far cheaper than the patented version (at Rs 1.5 lakhs) and therefore more accessible to patients in India.<br /><br /><em>Please <a href="http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/" title="http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/">click here</a> to read more. </em><br /></div>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 30030,
	'title' => 'Affordable Drugs Need a Compensatory Patent Commons -Shamnad Basheer',
	'subheading' => '',
	'description' => '<div align="justify">
-TheWire.in<br />
<br />
In a case that will once again prove that India is not out to arbitrarily purge all pharmaceutical patents, the Delhi high court has ruled in favour of Roche, a Swiss multinational. Many years ago, Roche dragged Cipla to court arguing that Cipla&rsquo;s product infringed its patented anticancer drug, Erlotinib (brand name &lsquo;Tarceva&rsquo;). After a protracted legal battle fought over seven hard years, Roche finally won.<br />
<br />
But so did Cipla. Indeed, the ingenuity of our judges is such that we&rsquo;ve craftily converted our patent system from a harsh zero sum game to a win-win for both. Cipla&rsquo;s gamble appears to have paid off. Here&rsquo;s how.<br />
<br />
In late 2008, in what will perhaps rate as one of the most adventurous patent joyrides ever, Cipla brazenly launched Erlocip, a generic version of Roche&rsquo;s patented Tarceva. Roche lost no time in initiating legal action before the Delhi High Court. Cipla mounted a spirited defence, challenging the validity of Roche&rsquo;s patent and taking shelter under the &ldquo;public interest&rdquo; defence, arguing that its generic version (sold at approx. Rs 50,000 a month) was far cheaper than the patented version (at Rs 1.5 lakhs) and therefore more accessible to patients in India.<br />
<br />
<em>Please <a href="http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/">click here</a> to read more. </em><br />
</div>',
	'credit_writer' => 'The Economic Times, 17 December, 2015, http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'affordable-drugs-need-a-compensatory-patent-commons-shamnad-basheer-4678089',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 4678089,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {},
		(int) 2 => object(Cake\ORM\Entity) {},
		(int) 3 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 30030
$metaTitle = 'LATEST NEWS UPDATES | Affordable Drugs Need a Compensatory Patent Commons -Shamnad Basheer'
$metaKeywords = 'generic medicine,generic medicines,patent,patents'
$metaDesc = '
-TheWire.in

In a case that will once again prove that India is not out to arbitrarily purge all pharmaceutical patents, the Delhi high court has ruled in favour of Roche, a Swiss multinational. Many years ago, Roche dragged Cipla to court...'
$disp = '<div align="justify">-TheWire.in<br /><br />In a case that will once again prove that India is not out to arbitrarily purge all pharmaceutical patents, the Delhi high court has ruled in favour of Roche, a Swiss multinational. Many years ago, Roche dragged Cipla to court arguing that Cipla&rsquo;s product infringed its patented anticancer drug, Erlotinib (brand name &lsquo;Tarceva&rsquo;). After a protracted legal battle fought over seven hard years, Roche finally won.<br /><br />But so did Cipla. Indeed, the ingenuity of our judges is such that we&rsquo;ve craftily converted our patent system from a harsh zero sum game to a win-win for both. Cipla&rsquo;s gamble appears to have paid off. Here&rsquo;s how.<br /><br />In late 2008, in what will perhaps rate as one of the most adventurous patent joyrides ever, Cipla brazenly launched Erlocip, a generic version of Roche&rsquo;s patented Tarceva. Roche lost no time in initiating legal action before the Delhi High Court. Cipla mounted a spirited defence, challenging the validity of Roche&rsquo;s patent and taking shelter under the &ldquo;public interest&rdquo; defence, arguing that its generic version (sold at approx. Rs 50,000 a month) was far cheaper than the patented version (at Rs 1.5 lakhs) and therefore more accessible to patients in India.<br /><br /><em>Please <a href="http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/" title="http://thewire.in/2015/12/17/affordable-drugs-need-a-compensatory-patent-commons-17509/">click here</a> to read more. </em><br /></div>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

Affordable Drugs Need a Compensatory Patent Commons -Shamnad Basheer

-TheWire.in In a case that will once again prove that India is not out to arbitrarily purge all pharmaceutical patents, the Delhi high court has ruled in favour of Roche, a Swiss multinational. Many years ago, Roche dragged Cipla to court arguing that Cipla’s product infringed its patented anticancer drug, Erlotinib (brand name ‘Tarceva’). After a protracted legal battle fought over seven hard years, Roche finally won. But so did Cipla. Indeed, the ingenuity of our judges is such that we’ve craftily converted our patent system from a harsh zero sum game to a win-win for both. Cipla’s gamble appears to have paid off. Here’s how. In late 2008, in what will perhaps rate as one of the most adventurous patent joyrides ever, Cipla brazenly launched Erlocip, a generic version of Roche’s patented Tarceva. Roche lost no time in initiating legal action before the Delhi High Court. Cipla mounted a spirited defence, challenging the validity of Roche’s patent and taking shelter under the “public interest” defence, arguing that its generic version (sold at approx. Rs 50,000 a month) was far cheaper than the patented version (at Rs 1.5 lakhs) and therefore more accessible to patients in India. Please click here to read more.